VIR earnings
Vir Biotechnology (VIR) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
VIR earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | 0.47 | 0.33 | 41.31% | $238.95M |
| Q1 2026 | May 6, 2026 | -0.85 | -0.01 | -8400.00% | -$29.00K |
| Q4 2025 | Feb 23, 2026 | -0.31 | -0.42 | 26.19% | $64.07M |
| Q3 2025 | Nov 5, 2025 | -1.17 | -0.70 | -67.14% | $240.00K |
| Q2 2025 | Aug 6, 2025 | -0.80 | -0.72 | -11.11% | $1.21M |
| Q1 2025 | May 7, 2025 | -0.88 | -0.83 | -6.02% | $3.03M |
| Q4 2024 | Feb 26, 2025 | -0.76 | -0.85 | 10.59% | $12.37M |
| Q3 2024 | Oct 31, 2024 | -1.56 | -0.96 | -62.50% | $2.38M |
| Q2 2024 | Aug 1, 2024 | -1.02 | -0.93 | -9.68% | $3.08M |
| Q1 2024 | May 2, 2024 | -0.48 | -0.99 | 51.52% | $56.38M |
| Q4 2023 | Feb 22, 2024 | -0.86 | -1.14 | 24.56% | $16.79M |
| Q3 2023 | Nov 2, 2023 | -1.22 | -1.21 | -0.83% | $2.64M |
| Aug 3, 2023 | -1.45 | -1.21 | -19.83% | – | |
| May 4, 2023 | -1.06 | -0.81 | -30.86% | – | |
| Feb 23, 2023 | -0.76 | -0.39 | -92.41% | – | |
| Nov 3, 2022 | 1.30 | -0.21 | 719.05% | – | |
| Aug 9, 2022 | -0.58 | -0.17 | -241.18% | – | |
| May 5, 2022 | 3.85 | 3.78 | 1.85% | – | |
| Feb 24, 2022 | 3.92 | 3.04 | 28.95% | – | |
| Nov 4, 2021 | 0.82 | 0.02 | 3487.05% | – |
- VIR reports next on Nov 4, 2026, with EPS of -0.75 expected.
- VIR beat EPS estimates in 11 of its last 28 reports.
Updated 2026-11-03 11:33 UTC